Lin Liu

机构：Dalian Municipal Central Hospital, Human Longevity (United States), University of California San Diego Medical Center, Children's Hospital of Chongqing Medical University, Chongqing Medical University · ORCID：0000-0002-6332-3064

发表论文 142 篇 · 总被引 4306 次 · h-index 34

代表论文

• Social Determinants of Health and Informed Consent Comprehension for Pediatric Cancer Clinical Trials (2023 · JAMA Network Open · 被引 19)
• A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with BRCA1/2 gene alterations (NePtune). (2024 · Journal of Clinical Oncology · 被引 7)
• Insufficient telomeric DNA damage response promotes chromosomal instability in aged oocytes (2025 · 中国科学通报：英文版 · 被引 6)
• Yield of Advanced Neoplasia at Second Post-polypectomy Surveillance Colonoscopy: A Systematic Review and Meta-analysis (2025 · Clinical Gastroenterology and Hepatology · 被引 6)
• Comparative effectiveness of implementation strategies for Accelerating Cervical Cancer Elimination through the integration of Screen-and-treat Services (ACCESS study): protocol for a cluster randomized hybrid type III trial in Nigeria (2024 · Implementation Science · 被引 5)
• Improvements in Vasopressor Requirements With Venovenous Extracorporeal Membrane Oxygenation (2024 · CHEST Critical Care · 被引 4)